Alaunos TherapeuticsTCRT
13F holders, Q2 2026 (June 30)29holders
6new positions
4sold out
1famous investor
$2.26avg. 13F price*
At the end of Q2 2026, 29 institutions reported holding Alaunos Therapeutics Inc. (TCRT) in their 13F filings, unchanged from Q1 2026. 6 opened new positions and 4 sold out. The largest holders were BlackRock, Inc. ($48K), Geode Capital Management, LLC ($44K) and Vanguard Fiduciary Trust Co. ($35K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Alaunos Therapeutics Inc.
- CUSIP
- 98973P309
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $3K |
| Exits | 4 | $98K |
All 13F filers, Q1 2026 → Q2 2026: 3,339 shares bought and 38,875 shares sold, net −35,536 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 29 holders
| BlackRock, Inc. | 0.00% | No change | 21,353 | $48K |
| Geode Capital Management, LLC | 0.00% | Reduce -14.2% | 19,356 | $44K |
| Vanguard Fiduciary Trust Co. | 0.00% | No change | 15,497 | $35K |
| Vanguard Capital Management LLC | 0.00% | No change | 14,063 | $32K |
| Citadel Advisors | 0.00% | Add +12.8% | 11,870 | $27K |
| Osaic Holdings, Inc. | 0.00% | Reduce -2.7% | 1,731 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +2.4% | 1,621 | $4K |
| Arax Advisory Partners | 0.00% | New | 1,216 | $3K |
| UBS Group AG | 0.00% | Reduce -56.4% | 992 | $2K |
| Morgan Stanley | 0.00% | Add +28.0% | 836 | $2K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 501 | $1K |
| Royal Bank of Canada | 0.00% | Add +102.7% | 375 | $1K |
| Wells Fargo & Company | 0.00% | Add +104.2% | 388 | $877 |
| Blue Trust, Inc. | 0.00% | No change | 135 | $305 |
| Steward Partners Investment Advisory, LLC | 0.00% | Add +21.7% | 112 | $253 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 70 | $158 |
| Bokf, NA | 0.00% | New | 66 | $149 |
| Axiom Investment Management LLC | 0.00% | New | 46 | $104 |
| Key Financial Inc | 0.00% | No change | 24 | $54 |
| Signaturefd, LLC | 0.00% | No change | 23 | $52 |
| NFSG Corp | 0.00% | No change | 21 | $47 |
| Lanark Financial, Inc. | 0.00% | No change | 20 | $45 |
| AdvisorNet Financial, Inc | 0.00% | No change | 19 | $43 |
| Barclays PLC | 0.00% | New | 15 | $34 |
| West Paces Advisors Inc. | 0.00% | New | 10 | $23 |
| Inspire Investing, LLC | 0.00% | No change | 9 | $20 |
| BNP Paribas Financial Markets | 0.00% | No change | 6 | $14 |
| IFG Advisory, LLC | 0.00% | New | 6 | $14 |
| Tidemark, LLC | 0.00% | No change | 2 | $5 |
"% of holder's portfolio" is TCRT's weight in each manager's 13F, not the share of Alaunos Therapeutics Inc. the manager owns.